Sphenopalatine Ganglion Block Study

PHASE1CompletedINTERVENTIONAL

Enrollment

220

Participants

Timeline

Start Date

March 6, 2023

Primary Completion Date

August 30, 2024

Study Completion Date

August 30, 2024

Conditions

Sphenopalatine Ganglion Nerve Block

Interventions

DRUG

Bupivacaine

Topically applied to sphenopalatine ganglion

DEVICE

angiocatheter

Introduced into nose to reach sphenopalatine ganglion nerve

Trial Locations (1)

Montefiore Medical Center, The Bronx

All Listed Sponsors

lead

Montefiore Medical Center

OTHER